NSCLC patients with oligo-metastatic brain disease show an altered CD4 T-cells immune profile
M. Alsousli, C. Maire, A. Piffko, J. Matschke, L. Glau, M. Reetz, S. Schneegans, G. Emurlai, B. Asey, A. Ruenger, S. Peine, J. Kropidlowski, J. Gempt, M. Glatzel, M. Westphal, , H. Wikman
The paper identifies altered CD4 T-cell immune profiles in NSCLC patients with oligo-metastatic brain disease compared to poly-metastatic disease and healthy controls.
bioRxiv · Apr 10, 2024 · PreprintCancer Biology